HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHTtm ? now ...

AI-powered models can analyze large datasets in real-time, optimizing organ distribution across wider geographic regions.

An end-of-trial biopsy was assessed by ... using a consensus read approach. Liver biopsies were also analyzed using two independent AI-based digital pathology tools (pre-specified).

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market impact. Read more on ALT stock here.

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

Detailed price information for Akero Therapeutics Inc (AKRO-Q) from The Globe and Mail including charting and trades.

RESULTS Presentation at index biopsy was jaundice in 24 patients, abnormal liver tests in 17, and hepatic failure in three. Antibiotics (n=13) and non-steroidal anti-inflammatory drugs (n=11) were the ...

Objective: To evaluate the role of chromohysteroscopy in improving diagnostic accuracy of endometrial biopsy in cases of AUB. Design: Cross sectional interventional study. Materials and Methods: This ...

Among them, (1) the patient is currently HBsAg positive, or HBsAg negative, anti-HBc positive and has been HBsAg positive for more than 6 months, and other causes are excluded; (2) liver biopsy ...

ucsd.edu Objective Patients with non-alcoholic fatty liver disease ... with contemporaneous MRE and biopsy-proven NAFLD. Non-alcoholic steatohepatitis-Clinical Research Network-Histologic Scoring ...